PubRank

Jean-Marc Chalopin

Author PubWeight™ 32.16‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cytomegalovirus exposure and cardiovascular disease in kidney transplant recipients. J Infect Dis 2013 2.72
2 Cytomegalovirus-associated venous thromboembolism in renal transplant recipients: a report of 7 cases. Transplantation 2004 1.73
3 Prolonged CD4 T cell lymphopenia increases morbidity and mortality after renal transplantation. J Am Soc Nephrol 2010 1.60
4 Relevance of Toll-like receptor-4 polymorphisms in renal transplantation. Kidney Int 2005 1.17
5 The first case of JC virus allograft nephropathy. Transplantation 2003 1.13
6 CD4 cell lymphopenia and atherosclerosis in renal transplant recipients. J Am Soc Nephrol 2003 1.08
7 Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 2004 1.05
8 Posttransplant diabetes mellitus and atherosclerotic events in renal transplant recipients: a prospective study. Transplantation 2005 0.99
9 IL-6 promoter polymorphism -174 is associated with new-onset diabetes after transplantation. J Am Soc Nephrol 2006 0.97
10 Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006 0.95
11 C-reactive protein and cardiovascular disease in peritoneal dialysis patients. Kidney Int 2002 0.92
12 Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study. Transplantation 2004 0.91
13 Thymoglobulin induction and sirolimus versus tacrolimus in kidney transplant recipients receiving mycophenolate mofetil and steroids. Transplantation 2010 0.91
14 Lymphocyte subsets and assessment of cancer risk in renal transplant recipients. Transpl Int 2002 0.90
15 Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation 2007 0.89
16 Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics. Perit Dial Int 2013 0.84
17 Pretransplant serum vitamin D levels and risk of cancer after renal transplantation. Transplantation 2008 0.83
18 Significant increase in 1-year posttransplant renal arterial index predicts graft loss. Clin J Am Soc Nephrol 2010 0.82
19 Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients. Kidney Int 2003 0.82
20 Thymic function, anti-thymocytes globulins, and cancer after renal transplantation. Transpl Immunol 2011 0.81
21 Treatment of hyperhomocysteinemia with folic acid reduces oxidative stress in renal transplant recipients. Transplantation 2002 0.79
22 Influence of fractalkine receptor gene polymorphisms V249I-T280M on cancer occurrence after renal transplantation. Transplantation 2013 0.79
23 No evidence of association between NOD2/CARD15 gene polymorphism and atherosclerotic events after renal transplantation. Transplantation 2006 0.79
24 Protective effect of intra-peritoneal epinephrine on postoperative renal function after cisplatin-based intra-peritoneal intra-operative chemotherapy. Eur J Obstet Gynecol Reprod Biol 2011 0.78
25 Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up. Transpl Int 2002 0.78
26 Influence of cyclooxygenase-2 (COX-2) gene promoter polymorphism at position -765 on skin cancer after renal transplantation. J Invest Dermatol 2010 0.78
27 Cytomegalovirus exposure, immune exhaustion and cancer occurrence in renal transplant recipients. Transpl Int 2012 0.78
28 Flow cytometric evaluation of pregnancy-induced anti-HLA immunization and blood transfusion-induced reactivation. Transplantation 2002 0.78
29 Rheumatoid purpura associated with toxocariasis. Can Fam Physician 2011 0.78
30 The interleukin-6 gene promoter polymorphism -174 and atherosclerotic events in overweight transplanted patients. J Transplant 2011 0.77
31 Impact of pre-transplant dialysis modality on post-transplant diabetes mellitus after kidney transplantation. Clin Transplant 2010 0.76
32 Alloimmune responses and atherosclerotic disease after kidney transplantation. Transplantation 2015 0.76
33 Hyperhomocysteinaemia therapy in haemodialysis patients: folinic versus folic acid in combination with vitamin B6 and B12. Nephrol Dial Transplant 2002 0.76
34 Homocysteine, nutritional status and insulin in renal transplant recipients. Nephrol Dial Transplant 2002 0.76
35 Six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts: serial baroreflex responses. Transpl Int 2004 0.75
36 Renal transplantation outcome in selected recipients with IgA nephropathy as native disease: a bicentric study. Ann Transplant 2012 0.75
37 The COX-2 gene promoter polymorphism -765 delays CD4 T-cell reconstitution after lymphocyte depletion with antithymocyte globulins. Hum Immunol 2011 0.75
38 G-765C COX-2 gene promoter polymorphism and risk of atherosclerosis after kidney transplantation. Transplantation 2009 0.75
39 Obesity and atherosclerotic events in chronic hemodialysis patients: a prospective study. Nephrol Dial Transplant 2013 0.75
40 [Tolerance in transplantation: potential contribution of haematopoietic transplantation and cell therapy]. Prog Urol 2003 0.75